We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




C-reactive Protein Level Can Replace Erythrocyte Sedimentation Rate for Defining the Severity of Ulcerative Colitis

By LabMedica International staff writers
Posted on 24 Feb 2022
Print article
Image: Representation of the structure of C-reactive protein (CRP) (Photo courtesy of Wikimedia Commons)
Image: Representation of the structure of C-reactive protein (CRP) (Photo courtesy of Wikimedia Commons)

A research team in Australia has determined that a blood level of C-reactive protein equal to or greater than 12 milligrams/liter is a practical alternative to measurement of ESR (Erythrocyte Sedimentation Rate) for defining the severity of ulcerative colitis.

Ulcerative colitis (UC) is an autoimmune disease characterized by T-cells infiltrating the colon. No direct causes for UC are known, but factors such as genetics, environment, and an overactive immune system play a role. UC is associated with complications that produce symptoms in many areas of the body outside the digestive system.

ESR as a component of the Truelove and Witts Criteria (TWC) is the traditional inflammatory marker used for the assessment of UC activity. However, C-reactive protein (CRP) is preferentially used in contemporary clinical practice. Investigators at the Royal Brisbane and Women's Hospital (Brisbane, Australia) sought to determine the equivalent CRP cut off for an ESR of greater than 30 millimeters/hour in patients presenting with acute severe UC.

CRP is a ring-shaped pentameric protein found in blood plasma, whose circulating concentrations rise in response to inflammation. It is an acute-phase protein of hepatic origin that increases following interleukin-6 secretion by macrophages and T-cells. Its physiological role is to bind to lysophosphatidylcholine expressed on the surface of dead or dying cells (and some types of bacteria) in order to activate the complement system via C1q. CRP is a more sensitive and accurate reflection of the acute phase response than the ESR. ESR may be normal while CRP is elevated. CRP returns to normal more quickly than ESR in response to therapy.

For this study, clinical and pathological data were prospectively collected from 163 presentations of severe UC. A CRP cut off corresponding to an ESR of greater than 30 millimeters/hour was determined using confusion matrices. A validation cohort of 128 presentations was prospectively collected and analyzed.

Results revealed that a CRP cutoff equal to or more than 12 milligrams/liter yielded a positive predictive value (PPV) of 85%, with sensitivity and accuracy of 95 and 82%, respectively, for having a paired ESR of greater than 30 millimeters/hour. No statistically significant differences were seen in presenting fecal calprotectin, Mayo endoscopic subscore, or in the rates of intravenous corticosteroid therapy failure and colectomy-by-discharge for the groups determined by traditional ESR versus the new CRP-based criteria. A PPV of 83% and sensitivity of 94% resulted from application of the CRP equal to or more than 12 milligrams/liter criterion to the validation cohort.

Based on these results, the investigators concluded that, "This work may influence clinical practice by relegating ESR as an admission blood test in acute presentations of UC. Utilizing the CRP-based criteria will improve accessibility to the clinical information required for a complete assessment of the Truelove and Witts Criteria. This will enable a shorter turnaround time for critical decision making regarding patient disposition and management."

The CRP vs. ESR study was published in the February 11, 2022, online edition of the Journal of Crohn's and Colitis.

Related Links:
Royal Brisbane and Women's Hospital 

 

New
Gold Member
ANCA IFA
Kallestad Autoimmune ANCA IFA Complete Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Human Papillomavirus Multiplex Assay
Anyplex Ⅱ HPV28 Detection
New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The new assays will run on the QIAcuity digital PCR (dPCR) platform (Photo courtesy of QIAGEN)

New Digital PCR Assays Enable Accurate and Sensitive Detection of Critical Pathogens

QIAGEN (Venlo, the Netherlands) has introduced 100 new assays for its QIAcuity digital PCR (dPCR) platform, aimed at advancing research in areas such as cancer, inherited genetic disorders, and infectious... Read more

Pathology

view channel
Image: The new AI technology more precisely predicts the risk of getting breast cancer (Photo courtesy of William Brøns Petersen)

AI Technology Accurately Predicts Breast Cancer Risk Via ‘Zombie Cells’

Breast cancer remains one of the most common cancers worldwide, causing 670,000 deaths in 2022. A key aspect of assessing cancer risk involves identifying dying cells. A new study has demonstrated that... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.